Novartis AG (NVS) Investment Research Dashboard
About Novartis AG (NVS) stock analysis
Get live NVS stock price $159.85, comprehensive Novartis AG stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time NVS stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscie...
Company Information
- CEO
- Vas Narasimhan
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 75267
Contact Information
- Website
- https://www.novartis.com
- Address
- Lichtstrasse 35
- Country
- CH
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 303.8 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 18.4)
✓ Lower volatility stock (Beta: 0.49) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Novartis AG shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Novartis AG
- ⚠Investors should consider how Novartis AG fits within their overall portfolio allocation
Market Cap
303.83B
P/E Ratio (TTM)
18.39
Beta
0.49
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare NVS with peer companies:
- Price
- $263.48+2.56% (1D)
- Market cap
- 465.51B
- Price
- $172.48+1.67% (1D)
- Market cap
- 133.67B
- Price
- $13.49+0.75% (1D)
- Market cap
- 53.01B
- Price
- $63.60+1.66% (1D)
- Market cap
- 129.88B
- Price
- $134.32+2.91% (1D)
- Market cap
- 166.77B
- Price
- $53.71+3.33% (1D)
- Market cap
- 108.36B
- Price
- $266.73+0.29% (1D)
- Market cap
- 642.79B
- Price
- $1,222.61+2.09% (1D)
- Market cap
- 1.15T
- Price
- $131.84+0.82% (1D)
- Market cap
- 325.61B
- Price
- $25.25+2.35% (1D)
- Market cap
- 143.91B
- Price
- $56.52+3.20% (1D)
- Market cap
- 360.27B
- Price
- $45.54+3.50% (1D)
- Market cap
- 110.48B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.8 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.4% | 29.2 | 46/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 35/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.